83 related articles for article (PubMed ID: 6434966)
1. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.
Tennant FS; Tarver AL; Rawson RA
NIDA Res Monogr; 1984 Mar; 49():239-46. PubMed ID: 6434966
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules.
Tennant FS; Tarver AL
NIDA Res Monogr; 1984; 55():291-7. PubMed ID: 6443388
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
5. Precessation treatment with nicotine skin patch facilitates smoking cessation.
Rose JE; Behm FM; Westman EC; Kukovich P
Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
[TBL] [Abstract][Full Text] [Related]
6. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
9. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption.
Amiaz R; Levy D; Vainiger D; Grunhaus L; Zangen A
Addiction; 2009 Apr; 104(4):653-60. PubMed ID: 19183128
[TBL] [Abstract][Full Text] [Related]
10. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
Westman EC; Levin ED; Rose JE
Arch Intern Med; 1993 Aug; 153(16):1917-23. PubMed ID: 8250653
[TBL] [Abstract][Full Text] [Related]
11. Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking.
Dallery J; Houtsmuller EJ; Pickworth WB; Stitzer ML
Psychopharmacology (Berl); 2003 Jan; 165(2):172-80. PubMed ID: 12417964
[TBL] [Abstract][Full Text] [Related]
12. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
[TBL] [Abstract][Full Text] [Related]
14. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
[TBL] [Abstract][Full Text] [Related]
15. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
17. Mecamylamine does not precipitate withdrawal in cigarette smokers.
Eissenberg T; Griffiths RR; Stitzer ML
Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
[TBL] [Abstract][Full Text] [Related]
18. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
[TBL] [Abstract][Full Text] [Related]
19. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
20. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
